The nationwide Covid-19 vaccine rollout has vaccinated millions of people, which helps to significantly reduce the number of new cases and protect the people of high risk, including cancer patients, from being infected. A fast vaccination will push the country entering the stage of herd immunity, namely enough population in…...
New publication by NFCR-supported scientist Rakesh Jain, Ph.D., applies cancer research findings to help COVID-19 treatment in different patient groups. Few drugs for COVID-19 appear to work well in unselected patients, but now a new mathematical model provides insight into which patients benefit from which treatments. Researchers and investigators, including…...
The COVID-19 pandemic has brought the world to its knees, preventing many events from taking place and closing the doors of uncountable businesses. People across the world were advised to stay inside and only leave the house for necessities. At first it was strange, uncomfortable, and scary. As time moved…...
Another deadly effect of the COVID-19 pandemic has recently been uncovered—significantly delayed cancer screenings. A recent study found that more than a third of Americans have missed life-saving cancer screenings because of the coronavirus. The reason? Americans have been too afraid to visit their doctor’s offices, making the decision to…...
Good news! Biotech company Moderna Inc. and government scientists at the National Institutes of Health report promising early results for coronavirus vaccine testing, currently in Phase 2 trials. A study published in the New England Journal of Medicine announced successful immune responses in all people who received the vaccine in…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
